ストックスクリーナーアプリを入手
6.18
5.21%
-0.34
アフターアワーズ：
6.18
前日終値:
$6.52
開ける：
$6.45
24時間の取引高:
526.08K
Relative Volume:
1.18
時価総額：
$410.09M
収益：
$555.06M
当期純損益:
$-39.48M
株価収益率:
-10.30
EPS:
-0.6
ネットキャッシュフロー:
$29.05M
1週間 パフォーマンス:
-5.94%
1か月 パフォーマンス:
-11.33%
6か月 パフォーマンス:
-42.13%
1年 パフォーマンス:
-11.71%
1日の値動き範囲:
$6.03
$6.50
1週間の範囲:
$6.03
$6.91
52週間の値動き範囲:
$6.02
$14.38
Bioventus Inc Stock (BVS) Company Profile
名前
Bioventus Inc
セクター
電話
(919) 474-6700
住所
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.18 | 432.65M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-12-07 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | アップグレード | Craig Hallum | Hold → Buy |
| 2022-11-22 | ダウングレード | Craig Hallum | Buy → Hold |
| 2022-11-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 開始されました | Craig Hallum | Buy |
| 2021-11-15 | 再開されました | Morgan Stanley | Overweight |
| 2021-11-10 | 再開されました | JP Morgan | Overweight |
| 2021-07-01 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-08 | 開始されました | Goldman | Buy |
| 2021-03-08 | 開始されました | JP Morgan | Overweight |
| 2021-03-08 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Bioventus Inc (BVS) 最新ニュース
What is Bioventus Inc. company’s growth strategyExceptional market positioning - jammulinksnews.com
What are analysts’ price targets for Bioventus Inc. in the next 12 monthsExponential wealth increase - jammulinksnews.com
How does Bioventus Inc. compare to its industry peersInvest confidently with advanced analysis tools - jammulinksnews.com
How volatile is Bioventus Inc. stock compared to the marketBuild wealth faster with consistent growth stocks - jammulinksnews.com
Bioventus gets FDA nod for pain management devices - MSN
What institutional investors are buying Bioventus Inc. stockHigh-yield investments - jammulinksnews.com
How strong is Bioventus Inc. company’s balance sheetAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
How does Bioventus Inc. generate profit in a changing economyUnlock expert insights for smarter investing - jammulinksnews.com
What are Bioventus Inc. company’s key revenue driversIdentify winners with top-tier analysis - jammulinksnews.com
Is Bioventus Inc. stock overvalued or undervaluedGet daily expert analysis for smarter investing - jammulinksnews.com
Should I hold or sell Bioventus Inc. stock in 2025Breakthrough capital growth - jammulinksnews.com
What analysts say about Bioventus Inc. stockUnmatched market gains - jammulinksnews.com
What catalysts could drive Bioventus Inc. stock higher in 2025Invest confidently with expert support - jammulinksnews.com
Is it the right time to buy Bioventus Inc. stockInvest smarter with real-time trading signals - jammulinksnews.com
Is Bioventus Inc. a growth stock or a value stockMaximize returns with strategic stock selection - jammulinksnews.com
What are the latest earnings results for Bioventus Inc.Robust financial gains - jammulinksnews.com
Market reaction to Bioventus Inc.’s recent newsSmart Safety Strategy With Real Data Analysis - Newser
Understanding Bioventus Inc.’s price movementLow Risk Stock Trade Opportunity Analysis - Newser
Competitive Positioning of Bioventus Inc.: Is It Leading or LaggingFree Daily Smart Money Movement Monitor - Newser
Bioventus Gains FDA Clearance for Key PNS Products - TipRanks
Top chart patterns to watch in Bioventus Inc.Buy Alert Based on RSI and Volume - Newser
Price action breakdown for Bioventus Inc.Yield Curve Outlook and Long-Term Implication Summary - Newser
What’s next for Bioventus Inc. stock priceAI Trend Detection for Entry Timing - Newser
Can Bioventus Inc. recover in the next quarterGrowth Watchlist for Long Term Positioning - Newser
How Bioventus Inc. stock performs during market volatilityCapital Growth With Controlled Risk Picks Suggested - beatles.ru
Bioventus receives FDA clearance for two pain management devices - Investing.com
Bioventus receives FDA clearance for two pain management devices By Investing.com - Investing.com UK
Bioventus gets FDA nod for pain management devices (BVS) - Seeking Alpha
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products - The Manila Times
The FDA Grants 510(k) Clearances For Bioventus' Talismann And Stimtrial, Expanding The Company's Portfolio Of Peripheral Nerve Stimulation Solutions For Chronic Pain Management - 富途牛牛
Bioventus Secures Dual FDA Clearance for Revolutionary Non-Opioid Pain Management Technology - Stock Titan
What makes Bioventus Inc. stock price move sharplySector-Wise Stock Strength Trend Analysis - Newser
Momentum divergence signals in Bioventus Inc. chartFree Reliable Chart-Based Trade Entries - Newser
New Product Launches: Will They Boost Bioventus Inc. Stock in 2025Breakout Monitoring with Momentum Analysis - Newser
What indicators show strength in Bioventus Inc.Stock Entry Points Based on Technicals - Newser
Bioventus Inc. Recovery Gathers Momentum on Chart SignalsRisk Adjusted Technical Entry Plan Gains Followers - metal.it
What candlestick patterns are forming on Bioventus Inc.Free Swing Setup With Technical Confirmation - Newser
What to do if you’re stuck in Bioventus Inc.Free Conservative Entry for High Return Setup - Newser
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025 - The Manila Times
Medical Innovation Leader Bioventus Announces Q2 2025 Earnings Date: Key Details for Investors - Stock Titan
Why Bioventus Inc. stock attracts strong analyst attentionReliable Alerts for Daily Stock Movers Released - metal.it
Regression Model Predicts Rangebound Movement in Bioventus Inc.AI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
What is the dividend policy of Bioventus Inc. stockInvest confidently with professional market insights - jammulinksnews.com
Bioventus Inc (BVS) 財務データ
収益
当期純利益
現金流量
EPS
1.21%
0.17%
大文字化:
|
ボリューム (24 時間):